Alva Health is developing a device that uses noninvasive wearables and AI/ML algorithms to monitor the onset of stroke symptoms and immediately initiate emergency calls. The wearable solution detects ...

In patients who could not afford new devices on their own, use of so-called "reconditioned" pacemakers met criteria for ...

A clinical trial testing muvalaplin, a novel oral medication, was able to safely and effectively lower high levels of ...

At AHA, Phase 2 results from Eli Lilly and Silence Therapeutics are seen as signs of a "major new path" of cardiovascular ...

Each year, over half a million Americans have a stroke, but up to 80% may be preventable with better nutrition, exercise and screening.

The highest dose of an experimental pill developed by Eli Lilly dramatically lowered an inherited form of high cholesterol in a mid-stage trial, according to data presented at a medical meeting on ...

CHICAGO -- Gene therapy for Danon disease, a rare inherited cause of hypertrophic cardiomyopathy, appeared to improve or ...

In positive early data from the RCT, sacubitril/valsartan given over 24 weeks reduced signs of heart damage in cancer ...

Pharmacists who received active feedback about their heart failure patients increased the frequency of their patient ...

For ventricular tachycardia after myocardial infarction, outcomes are better with upfront catheter ablation than drug therapy ...

Using an artificial intelligence program to read echocardiograms may reduce the wait time for results and help lead to more ...

A commonly prescribed medication for heart failure was linked to a lower risk of heart damage, or cardiotoxicity, among ...